ArticleThe journal of gene medicine2012
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.
Mariola Fotin-Mleczek et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this papertrialcites it